| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 保健品(元) | 1,894,839,650.06 | 939,646,735.62 | 1,621,954,500.49 | 755,301,048.43 |
| 维生素A系列(元) | 214,437,731.44 | 103,794,325.47 | 470,144,266.74 | 304,409,048.66 |
| 辅酶Q10(元) | 733,672,631.11 | 386,977,695.35 | 704,923,722.09 | 400,464,235.15 |
| 其他主营业务(元) | - | - | - | 400,464,235.15 |
| 其他(元) | 259,630,905.70 | 121,299,738.51 | 212,206,646.07 | 104,256,267.76 |
| 营业成本(元) | ||||
| 保健品(元) | 1,249,524,555.44 | 655,904,427.01 | 1,093,847,692.98 | 526,342,233.65 |
| 维生素A系列(元) | 222,823,838.23 | - | 319,283,772.46 | 163,637,044.40 |
| 辅酶Q10(元) | 323,428,714.80 | 162,762,135.82 | 249,360,110.19 | 129,017,104.27 |
| 其他主营业务(元) | - | - | - | 129,017,104.27 |
| 其他(元) | 148,708,234.75 | - | 128,352,152.61 | 66,732,734.87 |
| 毛利(元) | ||||
| 保健品(元) | 645,315,094.62 | 283,742,308.61 | 528,106,807.51 | 228,958,814.78 |
| 维生素A系列(元) | -8,386,106.79 | - | 150,860,494.28 | 140,772,004.26 |
| 辅酶Q10(元) | 410,243,916.31 | 224,215,559.53 | 455,563,611.90 | 271,447,130.88 |
| 其他主营业务(元) | - | - | - | 271,447,130.88 |
| 其他(元) | 110,922,670.95 | - | 83,854,493.46 | 37,523,532.89 |
| 毛利率(%) | ||||
| 保健品(%) | 34.06 | 30.20 | 32.56 | 30.31 |
| 维生素A系列(%) | -3.91 | - | 32.09 | 46.24 |
| 辅酶Q10(%) | 55.92 | 57.94 | 64.63 | 67.78 |
| 其他主营业务(%) | - | - | - | 67.78 |
| 其他(%) | 42.72 | - | 39.52 | 35.99 |
| 收入构成(%) | ||||
| 保健品(%) | 61.07 | 60.56 | 53.90 | 38.44 |
| 维生素A系列(%) | 6.91 | 6.69 | 15.62 | 15.49 |
| 辅酶Q10(%) | 23.65 | 24.94 | 23.43 | 20.38 |
| 其他主营业务(%) | - | - | - | 20.38 |
| 其他(%) | 8.37 | 7.82 | 7.05 | 5.31 |
| 毛利构成(%) | ||||
| 保健品(%) | 55.72 | 55.86 | 43.34 | 24.10 |
| 维生素A系列(%) | -0.72 | 0.00 | 12.38 | 14.82 |
| 辅酶Q10(%) | 35.42 | 44.14 | 37.39 | 28.57 |
| 其他主营业务(%) | - | - | - | 28.57 |
| 其他(%) | 9.58 | 0.00 | 6.88 | 3.95 |